FDA Class II · Drug · May 27, 2026
cimzia (certolizumab pegol) recall — UCB Biosciences Inc.
Lack of Assurance of Sterility
Official ID D-0546-2026 · Official record ↗
UCB Biosciences recalls
Recall found. UCB Biosciences is named in FDA Class II recall D-0546-2026 covering cimzia (certolizumab pegol). Hazard: Lack of Assurance of Sterility Identifying details: Lot: CVZFW, Exp.:2026-JUL-04; CVZYG, Exp.: 2026-AUG-19; CWSYT, Exp.: 2026-OCT-22; CWDZY, Exp.:2026-NOV-20; CWTSD, Exp.:2026-DEC-11; CVTFK, Exp.:2026-JUL-04; CVTSN, Exp.: 2026-AUG-19; CWVGP. Exp.:2026-DEC-11; CVWXT, CVWXV, CVWXW, Exp.:2026-JUL-04; CWHFF, Exp.: 2026-OCT-22; CWNDS, Exp.: 2026-DEC-11.. Status: Ongoing.
Models with recalls
All UCB Biosciences recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.